Navigation Links
Misonix Subsidiary, Sonora Medical Systems, Achieves ISO 17025 Accreditation
Date:6/18/2009

FARMINGDALE, N.Y., June 18 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that its subsidiary, Sonora Medical Systems, Inc. ("Sonora"), one of the world's leading suppliers of after market products, training, depot-level repair and support services, and test equipment to the medical imaging market, announced it has achieved ISO 17025 accreditation for its Acoustic Power Testing Laboratory. Acoustic power testing is a requirement for ultrasound system and probe manufacturers to obtain FDA 510(k) clearance of their products, as well as meet the International IEC60601 standards. In addition to the important foundation of a quality management system, the ISO 17025 standard specifically addresses the technical competence of the laboratory staff, the validity and appropriateness of the test methods, traceability of measurements to national standards, appropriate application of measurement uncertainty, suitability of test equipment and environment, and the quality of the test results and reports. Test data from ISO 17025 accredited laboratories is more readily accepted by worldwide regulatory and safety organizations, reducing cost and time to market globally for manufacturers.

Michael A. McManus, Jr., President and CEO of Misonix said, "This is one more validation of the ability of our employees at Sonora to develop new important acoustic power testing capability that is recognized by regulatory bodies as a high standard of accuracy and testing. Sonora performs more acoustic power testing for companies that design and develop diagnostic ultrasound systems than anyone in the world."

"We are very proud of the professionalism of our Sonora e
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
4. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
5. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
6. Misonix Announces New HIFU Distribution Agreement for Italy
7. Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern
8. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
9. Misonix Announces New Distribution Agreement for Israel
10. Misonix Announces New Sales Agency Agreement for Eastern Europe
11. Misonix Announces New Distribution Agreement for Belgium and Luxembourg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... October 01, 2014 Bedros Keuilian is ... Boot Camp fitness boot camps, he’s also considered the ... , with sold out business summits, a line of ... consultant to a recent Spike TV reality show to ... now is the time for personal trainers and fitness ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 ... networking and relationship-marketing firm, announced today the ... Executive® and Project of the Year Awards ... makers representing organizations in financial services, commercial, ... large-scale technology endeavors that address key issues ...
(Date:10/1/2014)... Hills, California (PRWEB) October 01, 2014 ... expert, Dr. Kathleen Mojas is celebrating 20 years of ... has assisted hundreds of people to achieve greater joy ... an important list of warning signs and suggestions for ... , Dr. Mojas explains: “Believe it or not, ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 NoteSwift Inc., ... EHR versions 10.0, 12.1 and 13.0. NoteSwift is the ... as commands to navigate and document clinical information at ... provider spends creating a patient note by more than ... of the major pain points providers state impedes EHR ...
(Date:10/1/2014)... Dar, Ethiopia, at the occasion of the Leishmaniasis ... 150 African and international leishmaniasis experts, results of ... efficacy monitoring plan, carried out by MSF, ... and Ethiopia, were presented to key decision makers ... of kala-azar with the combination of Sodium Stibogluconate ...
Breaking Medicine News(10 mins):Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2
... 2011.- The President of the BBVA Foundation, Francisco ... General Hospital Cancer Center (MGHCC), and Andrs de ... of Oncology (VHIO) in Barcelona, yesterday signed the ... Program. Also attending the event was the Foundation,s ...
... News) -- Women and younger men account for a large ... less likely than older men to receive preventive medications that ... evaluated more than 3,000 heart attack patients treated at the ... found that 70.3 percent of them had not been diagnosed ...
... the breast cancer drug tamoxifen in male breast cancer patients ... because of problems with side effects caused by the drug. ... in the cancer journal Annals of Oncology [1], ... their institution who had received tamoxifen for an average of ...
... Patients who rely on recombinant, protein-based drugs must ... week, or intravenous therapy. Researchers at Children,s Hospital ... from genetically engineered cells, could secrete the drug ... November 17 issue of the journal Blood ...
... Randy Dotinga HealthDay Reporter , TUESDAY, Nov. 15 ... doesn,t appear to improve the bone health of postmenopausal ... The treatment -- which involves standing on a motorized, vibrating ... promise in animals. But researchers, who hoped those results might ...
... be one of the topics of a conference at UC ... the UC Davis Center for Mind and Brain, Gallaudet University,s ... and the departments of psychology and linguistics at UC Davis. ... said David Corina, professor in the Department of Linguistics and ...
Cached Medicine News:Health News:Mass. General Cancer Center and Vall d'Hebron Institute of Oncology biomarker alliance 2Health News:Mass. General Cancer Center and Vall d'Hebron Institute of Oncology biomarker alliance 3Health News:Women, Younger Men Under-Treated Before Heart Attack: Study 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 3Health News:Engineered, drug-secreting blood vessels reverse anemia in mice 2Health News:Engineered, drug-secreting blood vessels reverse anemia in mice 3Health News:Whole-Body Vibration Doesn't Build Bone After All: Study 2Health News:Visual language, cognition and deaf education topics of summit 2
(Date:9/30/2014)... 2014  Tasly Pharmaceuticals, Inc., the world,s leader ... today the launch of Deepure. Deepure ... men and women concerned with supporting their overall ... age while helping keep their health care cost ... herb-based formulas, namely, ProHeart PLUS, ImmunoPower PLUS, and ...
(Date:9/30/2014)... , Sept. 30, 2014 Aileron ... Summary Global Markets Direct,s, ,Aileron Therapeutics, ... an overview of the Aileron Therapeutics, Inc.,s pharmaceutical ... comprehensive information on the current therapeutic developmental pipeline ... at various stages, therapeutics assessment by drug target, ...
(Date:9/30/2014)... DALLAS , September 30, 2014 /PRNewswire/ ... market research report the "Glycobiology/Glycomics Market by Product ... Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, ... Forecast to 2019", published by MarketsandMarkets, provides ... restraints, challenges, opportunities, current market trends, and ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4
... ... , MAPLE GROVE, Minn. , Jan. 27 ... Divigel ® (estradiol gel 0.1%), prescribed for the management of moderate-to-severe hot ... and compounded bioidentical hormones.(1) A review of the evidence was recently published in ...
... , , , , RALEIGH, N.C. , ... Research Organization, announces it has entered into a partnership agreement ... its exclusive partner IBPC, a non-profit oncology research network comprised ... treat an estimated 140,000 new incidences of cancer annually.  Under ...
Cached Medicine Technology:New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 2New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 3New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 4New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 5New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 6New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 7New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 8New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 9New Article: Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen 10PRA International Formalizes Partnership with Oncopartners and IBPC 2PRA International Formalizes Partnership with Oncopartners and IBPC 3PRA International Formalizes Partnership with Oncopartners and IBPC 4PRA International Formalizes Partnership with Oncopartners and IBPC 5
0.2 mm, 90o angled tip. Flat smooth handle with polished finish....
Nucleus manipulator facilitates lens rotation during phacoemulsification....
Straight shaft with 0.2 mm hour glass shape tip. Round knurled handle with dull finish. Manufactured in titanium....
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Medicine Products: